Zobrazeno 1 - 10 of 99 pro vyhledávání: '"Toffart AC"'
1
Akademický článek
Current opinions in immune checkpoint inhibitors rechallenge in solid cancers
Autor: Gobbini, E. *, Charles, J., Toffart, AC., Leccia, MT, Moro-Sibilot, D., Giaj Levra, M.
Publikováno v: In Critical Reviews in Oncology / Hematology December 2019 144
Zobrazit plný text záznamu
3
Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data
Autor: Darmon, M, Bourmaud, A, Georges, Q, Soares, M, Jeon, K, Oeyen, S, Rhee, CK, Gruber, P, Ostermann, M, Hill, QA, Depuydt, P, Ferra, C, Toffart, AC, Schellongowski, P, Muller, A, Lemiale, V, Mokart, D, Azoulay, E
Publikováno v: Intensive Care Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
PurposeThe number of averted deaths due to therapeutic advances in oncology and hematology is substantial and increasing. Survival of critically ill cancer patients has also improved during the last 2decades. However, these data stem predominantly fr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fb9389a689172bf0e7b9e1f98db97e66
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3769
Zobrazit plný text záznamu
4
Akademický článek
Giant sternal condrosarcoma.
Autor: Pirvu A, Pop O, Villa J, Sakhri L, Toffart AC, Pirvu, Augustin, Pop, Oana, Villa, Julie, Sakhri, Linda, Toffart, Anne Claire
Publikováno v: Journal of Thoracic Oncology; 2012 Dec, Vol. 7 Issue 12, p1879-1879, 1p
Zobrazit plný text záznamu
5
Akademický článek
Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib.
Autor: Pop O, Pirvu A, Toffart AC, Moro-Sibilot D
Publikováno v: Journal of Thoracic Oncology; 2012 Aug, Vol. 7 Issue 8, pe1-2, 1p
Zobrazit plný text záznamu
6
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial
Autor: Girard, Nicolas, Ponce Aix, Santiago, cedres, susana, Berghmans, Thierry, Burgers, Sjaak, Toffart, Anne-Claire
Publikováno v: Scientia
Immunotherapy; Thymic carcinoma; Thymoma Immunoteràpia; Carcinoma tímic; Timoma Inmunoterapia; Carcinoma tímico; Timoma Background Thymic malignancies are rare intrathoracic tumors, which may be aggressive and difficult to treat. They represent a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3991::c628be05d28bfc803606ed278642d822
https://hdl.handle.net/11351/9737
Zobrazit plný text záznamu
7
Akademický článek
Agreement and comparative accuracy of instability criteria at discharge for predicting adverse events in patients with community-acquired pneumonia.
Autor: Danjou A; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France., Bouisse M; Clinical Epidemiology Unit, Grenoble Alpes University Hospital, Grenoble, France., Boussat B; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.; Clinical Epidemiology Unit, Grenoble Alpes University Hospital, Grenoble, France.; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada., Blaise S; Department of Vascular Medicine, Grenoble Alpes University Hospital, Grenoble, France.; Université Grenoble Alpes, HP2, INSERM U1042, Grenoble, France., Gaillat J; Department of Infectious Diseases, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., Francois P; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.; Clinical Epidemiology Unit, Grenoble Alpes University Hospital, Grenoble, France., Courtois X; Service Information et Evaluation Médicale, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., Sellier E; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.; Service d'Information Médicale, Grenoble Alpes University Hospital, Grenoble, France., Toffart AC; Department of Thoracic Oncology, Grenoble Alpes University Hospital, Grenoble, France.; Institute for Advanced Biosciences, UGA/INSERM U1209/CNRS 5309, Université Grenoble Alpes, Grenoble, France., Schwebel C; Intensive Care Unit, Grenoble Alpes University Hospital, Grenoble, France., Halm EA; Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Labarere J; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France JLabarere@chu-grenoble.fr.; Clinical Epidemiology Unit, Grenoble Alpes University Hospital, Grenoble, France.; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Publikováno v: BMJ open respiratory research [BMJ Open Respir Res] 2024 Nov 07; Vol. 11 (1). Date of Electronic Publication: 2024 Nov 07.
Zobrazit plný text záznamu
8
Akademický článek
Different pathways to lung cancer diagnosis in a real-life setting.
Autor: Raëth J; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France. Electronic address: jraeth@chu-grenoble.fr., Malbert C; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France., Pinsolle J; Department of Pneumology, CH Metropole-Savoie, Chambery, France., Arbib F; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France., Ferretti GR; Department of Diagnostic and Interventional Radiology, University of Grenoble Alpes, and CHU Grenoble Alpes, Grenoble, France., Degano B; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France., Benet J; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France., Berardi G; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France., Fedi A; Department of Pneumology, Centre Henri Bazire, La Sure en Chartreuse, and Clinique Mutualiste, Grenoble, France., Toffart AC; Department of Pneumology, CHU Grenoble Alpes Grenoble, Grenoble, France.
Publikováno v: Respiratory medicine and research [Respir Med Res] 2024 Nov; Vol. 86, pp. 101108. Date of Electronic Publication: 2024 Apr 24.
Zobrazit plný text záznamu
9
Akademický článek
PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling.
Autor: Gazzeri S; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France sylvie.gazzeri@univ-grenoble-alpes.fr., Zubchuk N; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France., Montaudon E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Huot-Marchand S; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France., Berardi G; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, Grenoble, France., Pucciarelli A; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France., Dib Y; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France., Nerini D; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France., Oddou C; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team Epigenetics, Immunity, Metabolism, Cell Signaling and Cancer, Institute for Advanced Biosciences, Grenoble, France., Pezet M; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Platform MicroCell, Institute for Advanced Biosciences, Grenoble, France., David-Boudet L; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., Ardin C; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France.; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, Grenoble, France., de Fraipont F; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France.; Medical Unit of Molecular Genetic (Hereditary Diseases and Oncology), Grenoble-Alpes University Hospital, Grenoble, France., Maraver A; Institut de Recherche en Cancérologie de Montpellier, INSERM U1194-ICM-Université de Montpellier, Montpellier, France., Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France., Decaudin D; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., Toffart AC; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France.; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, Grenoble, France., Eymin B; University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team RNA Splicing, Cell Signaling and Response to Therapy, Institute for Advanced Biosciences, Grenoble, France beatrice.eymin@univ-grenoble-alpes.fr.
Publikováno v: Life science alliance [Life Sci Alliance] 2024 Oct 01; Vol. 7 (12). Date of Electronic Publication: 2024 Oct 01 (Print Publication: 2024).
Zobrazit plný text záznamu
10
Akademický článek
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study.
Autor: Ferreira M; Department of Pneumology and Respiratory Functional Exploration, University Hospital of Tours, Tours, France., Swalduz A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Greillier L; Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France., du Rusquec P; Thorax Institute Curie Montsouris, Institut Curie, Paris, France., Curcio H; Centre François Baclesse, Caen, France., Raimbourg J; Department of Medical Oncology, ICO-Centre René Gauducheau, St Herblain, France., Toffart AC; Pulmonology Unit, Grenoble University Hospital, Grenoble, France., Gounant V; Service d'Oncologie Thoracique Hôpital Bichat, AP-HP, Paris, France., Couraud S; Acute Respiratory Medicine and Thoracic Oncology Department, Cancer Institute of Hospices Civils de Lyon, Lyon Sud Hospital, Pierre Bénite, France., De Chabot G; Centre Hospitalier Bretagne Atlantique, Vannes, France., Friard S; Hôpital Foch, Suresnes, France., Hureaux J; CHU Angers, Angers, France., Jeannin G; CHU Clermont-Ferrand, Clermont-Ferrand, France., Odier L; Hopital Nord-Ouest de Villefranche-sur-Saône, Gleize, France., Ricordel C; CHU Rennes, Rennes, France., Wislez M; Service de Pneumologie, Unité d'Oncologie Thoracique hôpital Cochin, AP-HP, Paris, France; Equipe 'Cancer, Immune Control and Escape' Inserm U1138 Centre de Recherches des Cordeliers Université de Paris Cité., Descarpentries C; Department of Biochemistry and Molecular Biology «Hormonology Metabolism Nutrition Oncology», CHU Lille, F-59000 Lille, France., Herbreteau G; Hôtel-Dieu, Laboratoire de biochimie, Plateforme de génétique des cancers, CHU Nantes, Nantes, France., Missy P; Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Morin F; Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Westeel V; Service de Pneumologie, Hôpital Jean Minjoz, Besançon, France., Cortot AB; Department of Thoracic Oncology, CHU de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-U1277-CANTHER, Lille, France. Electronic address: alexis.cortot@chru-lille.fr.
Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Oct; Vol. 196, pp. 107934. Date of Electronic Publication: 2024 Aug 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje